Chemical Component Summary

NameCHLORAMPHENICOL SUCCINATE
Identifiers4-[(2R,3R)-2-(2,2-dichloroethanoylamino)-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxo-butanoic acid
FormulaC15 H16 Cl2 N2 O8
Molecular Weight423.20
TypeNON-POLYMER
Isomeric SMILESc1cc(ccc1[C@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
InChIInChI=1S/C15H16Cl2N2O8/c16-14(17)15(24)18-10(7-27-12(22)6-5-11(20)21)13(23)8-1-3-9(4-2-8)19(25)26/h1-4,10,13-14,23H,5-7H2,(H,18,24)(H,20,21)/t10-,13-/m1/s1
InChIKeyLIRCDOVJWUGTMW-ZWNOBZJWSA-N

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count2
Bond Count43
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB07565 
NameChloramphenicol succinate
Groupsapproved
DescriptionChloramphenicol succinate is an ester prodrug of [chloramphenicol].[A192987] Chloramphenicol is a bacteriostatic antibiotic.[A204065] Use of chloramphenicol succinate and chloramphenicol has decreased due to the risk of potentially fatal blood dyscrasias.[L14174] Chloramphenicol succinate was granted FDA approval on 20 February 1959.[L12711]
Synonyms
  • Chloramphenicol sodium succinate
  • Chloramphenicol hemisuccinate
  • Chloramphenicol succinate
Brand Names
  • Chloromycetin Sodium Succinate
  • Chloramphenicol Sodium Succinate
  • Chloromycetin Succinate Injection 1gm
IndicationChloramphenicol succinate is indicated to treat serious and susceptible bacterial infections where less dangerous drugs are ineffective or contraindicated.[L12711]
Categories
  • Alcohols
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Benzene Derivatives
  • Glycols
CAS number3544-94-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Dr hemagglutinin structural subunitMKKLAIMAAASMVFAVSSAHAGFTPSGTTGTTKLTVTEECQVRVGDLTVA...unknowninhibitor
Chloramphenicol acetyltransferase 3MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKF...unknownsubstrate
Serum albuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownbinder
P-glycoprotein 1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem656580
ChEBICHEBI:3606
ChEMBLCHEMBL1201281